Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 49

1.

Up-regulation of PDCD4 in senescent human diploid fibroblasts.

Kang MJ, Ahn HS, Lee JY, Matsuhashi S, Park WY.

Biochem Biophys Res Commun. 2002 Apr 26;293(1):617-21.

PMID:
12054647
2.

Translation initiation and its deregulation during tumorigenesis.

Watkins SJ, Norbury CJ.

Br J Cancer. 2002 Apr 8;86(7):1023-7. Review.

3.

Tumstatin, an endothelial cell-specific inhibitor of protein synthesis.

Maeshima Y, Sudhakar A, Lively JC, Ueki K, Kharbanda S, Kahn CR, Sonenberg N, Hynes RO, Kalluri R.

Science. 2002 Jan 4;295(5552):140-3.

4.

Translation initiation factor eIF-4G is immunogenic, overexpressed, and amplified in patients with squamous cell lung carcinoma.

Bauer C, Diesinger I, Brass N, Steinhart H, Iro H, Meese EU.

Cancer. 2001 Aug 15;92(4):822-9.

PMID:
11550153
5.

Modulation of the helicase activity of eIF4A by eIF4B, eIF4H, and eIF4F.

Rogers GW Jr, Richter NJ, Lima WF, Merrick WC.

J Biol Chem. 2001 Aug 17;276(33):30914-22. Epub 2001 Jun 19.

6.

Eukaryotic initiation factors 4A (eIF4A) and 4G (eIF4G) mutually interact in a 1:1 ratio in vivo.

Li W, Belsham GJ, Proud CG.

J Biol Chem. 2001 Aug 3;276(31):29111-5. Epub 2001 Jun 14.

7.

Extracellular matrix-derived peptide binds to alpha(v)beta(3) integrin and inhibits angiogenesis.

Maeshima Y, Yerramalla UL, Dhanabal M, Holthaus KA, Barbashov S, Kharbanda S, Reimer C, Manfredi M, Dickerson WM, Kalluri R.

J Biol Chem. 2001 Aug 24;276(34):31959-68. Epub 2001 Jun 8.

8.

The requirement for eukaryotic initiation factor 4A (elF4A) in translation is in direct proportion to the degree of mRNA 5' secondary structure.

Svitkin YV, Pause A, Haghighat A, Pyronnet S, Witherell G, Belsham GJ, Sonenberg N.

RNA. 2001 Mar;7(3):382-94.

9.

A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-kappaB or ODC transactivation.

Yang HS, Jansen AP, Nair R, Shibahara K, Verma AK, Cmarik JL, Colburn NH.

Oncogene. 2001 Feb 8;20(6):669-76.

10.

Further characterization of the helicase activity of eIF4A. Substrate specificity.

Rogers GW Jr, Lima WF, Merrick WC.

J Biol Chem. 2001 Apr 20;276(16):12598-608. Epub 2001 Jan 16.

11.

Characterization of the two eIF4A-binding sites on human eIF4G-1.

Korneeva NL, Lamphear BJ, Hennigan FL, Merrick WC, Rhoads RE.

J Biol Chem. 2001 Jan 26;276(4):2872-9. Epub 2000 Nov 1.

12.

Novel eIF4G domain homologues linking mRNA translation with nonsense-mediated mRNA decay.

Ponting CP.

Trends Biochem Sci. 2000 Sep;25(9):423-6. No abstract available.

PMID:
10973054
14.

Activator protein 1 (AP-1)- and nuclear factor kappaB (NF-kappaB)-dependent transcriptional events in carcinogenesis.

Hsu TC, Young MR, Cmarik J, Colburn NH.

Free Radic Biol Med. 2000 May 1;28(9):1338-48. Review.

PMID:
10924853
16.

eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation.

Gingras AC, Raught B, Sonenberg N.

Annu Rev Biochem. 1999;68:913-63. Review.

PMID:
10872469
17.
19.

Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation.

Cmarik JL, Min H, Hegamyer G, Zhan S, Kulesz-Martin M, Yoshinaga H, Matsuhashi S, Colburn NH.

Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):14037-42.

20.

Eukaryotic translation initiation factor 4AIII (eIF4AIII) is functionally distinct from eIF4AI and eIF4AII.

Li Q, Imataka H, Morino S, Rogers GW Jr, Richter-Cook NJ, Merrick WC, Sonenberg N.

Mol Cell Biol. 1999 Nov;19(11):7336-46.

Supplemental Content

Support Center